Chemicals classified as ζ2-COP Inhibitors encompass a range of compounds that can indirectly influence the function and activity of the ζ2-COP protein by targeting various cellular processes and signaling pathways related to vesicular trafficking and cellular structure organization. For instance, compounds like Brefeldin A and Golgicide A specifically disrupt Golgi apparatus function, which is a crucial node in the vesicular transport pathways involving the COP complex. By altering the structural integrity and function of the Golgi, these inhibitors can indirectly affect the role of ζ2-COP in mediating the transport of proteins.
Moreover, the application of inhibitors that target cytoskeletal components, such as Cytochalasin D, Nocodazole, and Latrunculin B, highlights the importance of the cytoskeleton in facilitating vesicular transport processes that the COP complex is involved in. These compounds, by modulating the dynamics of actin filaments and microtubules, potentially influence the trafficking routes and efficiency of vesicle movement, thereby indirectly affecting ζ2-COP's function within these pathways. Additionally, the use of kinase inhibitors like H89, as well as compounds affecting molecular motors and actin polymerization regulators like ML141 and Wiskostatin, underscores the complex regulation of vesicular transport and the potential for these inhibitors to modulate the cellular environment and signaling pathways in which ζ2-COP operates.
This broad approach to identifying inhibitors that can indirectly impact ζ2-COP function provides a comprehensive perspective on the potential strategies for modulating vesicular trafficking and the role of the COP complex in maintaining cellular homeostasis. By targeting the interconnected signaling pathways and cellular structures that facilitate the COP complex's activities, these compounds offer insights into the mechanisms through which ζ2-COP activity could be influenced, offering avenues for further research into the regulation of vesicular transport and the development of strategies targeting these processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts Golgi structure and function, potentially affecting COP-mediated vesicular trafficking. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
Specifically targets the Golgi BFA resistance factor 1, indirectly impacting COP function. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $92.00 $182.00 | 71 | |
PKA inhibitor, could alter phosphorylation states affecting COP complex assembly or function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin, potentially affecting vesicular scission, indirectly impacting COP's role in trafficking. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Disrupts actin polymerization, potentially affecting vesicle movement and COP function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Disrupts Golgi function, which may indirectly impact COP-mediated vesicular trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Disrupts microtubule polymerization, potentially affecting vesicular transport and COP function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Stabilizes microtubules, which could indirectly influence COP-mediated transport processes. | ||||||
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $229.00 | 29 | |
Disrupts actin filaments, potentially affecting vesicle movement and COP function. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes actin filaments, indirectly impacting vesicular trafficking and COP function. | ||||||